You are currently viewing a new version of our website. To view the old version click .
Biomolecules
  • Correction
  • Open Access

31 March 2023

Correction: Luedemann et al. Prostate Cancer-Associated miRNAs in Saliva: First Steps to an Easily Accessible and Reliable Screening Tool. Biomolecules 2022, 12, 1366

,
,
,
,
,
,
and
1
Department of Internal Medicine, Gastroenterology, Hepatology, Infectiology, Nephrology, Endocrinology & Diabetology, University Hospital of Bonn, 53127 Bonn, Germany
2
Division of Functional Genomics, Chair for Biochemistry and Molecular Medicine, University of Witten/Herdecke, 58453 Witten, Germany
3
Department of General, Visceral and Vascular Surgery, Marienhospital Brühl, 50321 Brühl, Germany
4
Center for Biochemical Education and Research (ZBAF), University of Witten/Herdecke, 58453 Witten, Germany
The authors wish to make the following corrections to their paper [1]. Eight sequences were missed in the original Table 3. The correct version appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Table 3. Primer assays ID and sequence, acquired from Qiagen®.

Reference

  1. Luedemann, C.; Reinersmann, J.-L.; Klinger, C.; Degener, S.; Dreger, N.M.; Roth, S.; Kaufmann, M.; Savelsbergh, A. Prostate Cancer-Associated miRNAs in Saliva: First Steps to an Easily Accessible and Reliable Screening Tool. Biomolecules 2022, 12, 1366. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.